# Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/increased-tuberculosis-reactivation-risk-in-patients-receiving-immune-checkpoint/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hsing-Wu Chen,Yao-Wen Kuo,Chung‐Yu Chen,Chin-Hao Chang,Chin-Hao Chang,Su-Mei Wang,Ying‐Chun Chien,Jo‐Pai Chen,Jo-Pai Chen,Cheng‐Yu Chang,Shih‐Chieh Chang,Yu‐Feng Wei,Shih-Chieh Chang,Chin‐Chung Shu,Hao‐Chien Wang,Wei‐Yu Liao,Hao‐Chien Wang,Chong‐Jen Yu |
| Citations | 25 |
| DOI | 10.1093/oncolo/oyad340 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad340/56147999/oyad340.pdf |
| OpenAlex ID | https://openalex.org/W4390904845 |
| PMID | 38227604 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Cheng‐Yu Chang](https://scholariq.org/researchers/cheng-yu-chang/)

## Paper journal

- [The Oncologist](https://scholariq.org/journals/the-oncologist/)

## Paper primary topic

- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)

## Paper topics

- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Diagnosis and treatment of tuberculosis](https://scholariq.org/topics/diagnosis-and-treatment-of-tuberculosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.